Literature DB >> 15882255

Role of coagulation factor Xa and protease-activated receptor 2 in human mesangial cell proliferation.

Misa Tanaka1, Hidenori Arai, Ning Liu, Fumiaki Nogaki, Keiko Nomura, Kenji Kasuno, Emi Oida, Toru Kita, Takahiko Ono.   

Abstract

BACKGROUND: Fibrin deposition and mesangial cell proliferation are frequently observed in the active type of mesangioproliferative glomerulonephritis. Coagulation factors, such as factor V and factor Xa are colocalized with fibrin in the mesangial areas in active type of IgA nephropathy with mesangial cell proliferation. In this study, therefore, we studied the role of factor Xa and its receptor, protease-activated receptor 2 (PAR2) in mesangial cell proliferation and fibrin deposition, and examined ant-proliferative effects of a specific factor Xa inhibitor, DX-9065a, in cultured human mesangial cells.
METHODS: To examine the effect of DX-9065a on the factor Xa-induced proliferation of cultured human mesangial cells, we measured thymidine incorporation and cell numbers. We also examined the effect of DX-9065a on extracellular regulated kinase (ERK) activation and fibrin production induced by factor Xa in human mesangial cells.
RESULTS: Factor Xa increased [(3)H]-thymidine incorporation and cell numbers in a dose-dependent manner in mesangial cells, which was inhibited by DX-9065a. DX-9065a also suppressed factor Xa-triggered fibrin deposition on mesangial cell surface. Factor Xa induced the activation of ERK in mesangial cells and this activation was also completely inhibited by DX-9065a, but not inhibited by PAR1 antagonist. Factor Xa-induced cell proliferation and ERK activation were inhibited by PD98059.
CONCLUSION: There results suggest that factor Xa can induce mesangial cell proliferation through the activation of ERK via PAR2 in mesangial cells and that PAR2 may play a crucial role in the cell proliferation induced by factor Xa. Our results implicate that DX-9065a may be a promising agent to regulate proliferation of mesangial cellss and inhibit the coagulation process in mesangium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882255     DOI: 10.1111/j.1523-1755.2005.00317.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

Review 2.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

Review 3.  The domino effect triggered by the tethered ligand of the protease activated receptors.

Authors:  Xu Han; Marvin T Nieman
Journal:  Thromb Res       Date:  2020-08-04       Impact factor: 3.944

4.  Soluble fibrin formation in the mesangial area of IgA nephropathy.

Authors:  Ning Liu; Noriko Mori; Noriyuki Iehara; Kazuhide Uemura; Atsushi Fukastu; Toru Kita; Michio Matsuda; Takahiko Ono
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

5.  Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation.

Authors:  Keren Borensztajn; Jurriën Stiekema; Sebastiaan Nijmeijer; Pieter H Reitsma; Maikel P Peppelenbosch; C Arnold Spek
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

6.  Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells.

Authors:  Jacky Y Suen; Brooke Gardiner; Sean Grimmond; David P Fairlie
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

Review 7.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

8.  Protease-activated receptor-2 augments experimental crescentic glomerulonephritis.

Authors:  Leon Moussa; Jim Apostolopoulos; Piers Davenport; Jorge Tchongue; Peter G Tipping
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

9.  Membranoproliferative glomerulonephritis and a rare bleeding disorder: Factor X deficiency.

Authors:  T Basturk; E Ahbap; B Eroglu Kesim; M Yılmaz; Y Koç; T Sakacı; A Unsal
Journal:  Int Urol Nephrol       Date:  2010-09-23       Impact factor: 2.370

10.  PR3 and elastase alter PAR1 signaling and trigger vWF release via a calcium-independent mechanism from glomerular endothelial cells.

Authors:  Samantha P Tull; Anne Bevins; Sahithi Jyothsna Kuravi; Simon C Satchell; Bahjat Al-Ani; Stephen P Young; Lorraine Harper; Julie M Williams; George Ed Rainger; Caroline O S Savage
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.